| AVURX | DOXGX | AVURX / DOXGX | |
| Total Expense Ratio | 1.45 | 0.41 | 354% |
| Annual Report Gross Expense Ratio | 1.48 | 0.46 | 322% |
| Fund Existence | 21 years | 4 years | - |
| Gain YTD | 17.446 | 8.891 | 196% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.97B | 118B | 2% |
| Annual Yield % from dividends | 0.91 | 1.14 | 79% |
| Returns for 1 year | 17.62 | 14.64 | 120% |
| Returns for 3 years | 21.75 | 117.62 | 18% |
| Returns for 5 years | 4.98 | N/A | - |
| Returns for 10 years | 30.23 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EZMO | 25.44 | 0.19 | +0.77% |
| AlphaDroid Broad Markets Momentum ETF | |||
| DTD | 95.29 | 0.25 | +0.26% |
| WisdomTree US Total Dividend ETF | |||
| ITDH | 41.96 | 0.11 | +0.26% |
| iShares LifePath Target Date 2060 ETF | |||
| IBDZ | 25.58 | -0.06 | -0.23% |
| iShares iBonds Dec 2034 Term Corp ETF | |||
| PBE | 89.61 | -1.49 | -1.64% |
| Invesco Biotechnology & Genome ETF | |||